non-vasospastic subjects
Showing 1 - 25 of >10,000
Aneurysmal Subarachnoid Hemorrhage, Vasospasm, Intracranial, Stenosis Trial in Brussel (Chemical and Mechanical Angioplasty for
Recruiting
- Aneurysmal Subarachnoid Hemorrhage
- +5 more
- Chemical and Mechanical Angioplasty for Refractory Intracranial Arterial Vasospastic Stenosis
-
Brussel, BelgiumErasme Hospital
Feb 24, 2022
Alzheimer Trial in Beijing (XTR006)
Recruiting
- Alzheimer Disease
-
Beijing, Beijing Shi, ChinaChinese PLA General Hospital
Nov 21, 2023
Atherosclerosis, Periodontitis Trial in Catania (Non-surgical periodontal treatment)
Recruiting
- Atherosclerosis
- Periodontitis
- Non-surgical periodontal treatment
-
Catania, ItalyAOU Policlinico G. Rodolico
Jun 7, 2023
Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)
Not yet recruiting
- Relapsed or Refractory Non-Hodgkin's Lymphoma
-
Beijing, China
- +3 more
Jul 20, 2023
Atherosclerosis, Endothelial Dysfunction, Peri-Implantitis Trial in Catania (Non-surgical periodontal treatment)
Recruiting
- Atherosclerosis
- +3 more
- Non-surgical periodontal treatment
-
Catania, ItalyAOU Policlinico G. Rodolico
Jun 7, 2023
Lipodystrophy, Dunnigan Syndrome Trial in Saint-Pierre (Bood and urine sampling)
Recruiting
- Lipodystrophy
- Dunnigan Syndrome
- Bood and urine sampling
-
Saint-Pierre, RéunionCHU La Réunion DRCI
Oct 27, 2023
Coronary Microvascular Dysfunction, Microvascular Angina, Vasospasm, Coronary Trial in Germany, Switzerland (Bisoprolol,
Recruiting
- Coronary Microvascular Dysfunction
- +5 more
- Bisoprolol
- +2 more
-
Bad Nauheim, Germany
- +14 more
Mar 15, 2022
Non-Alcoholic Fatty Liver Disease Trial in Hong Kong (SIM01)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- SIM01
-
Hong Kong, Hong KongGenieBiome Limited
May 22, 2023
Healthy Volunteer Study Trial in San Antonio (CBP-4888, Placebo)
Recruiting
- Healthy Volunteer Study
- CBP-4888
- Placebo
-
San Antonio, TexasComanche Biopharma Clinical Research Site #1
Jun 1, 2023
Cardiogenic Acute Pulmonary Edema in Subjects Over 75 Years Old:
Recruiting
- Cardiogenic Pulmonary Edema
-
Strasbourg, FranceGériatrie - Service de Soins de Soins Médicaux et de Réadaptatio
Oct 24, 2023
Non-Hodgkin Lymphoma Trial in Taiwan, United States (CHO-H01)
Recruiting
- Non-Hodgkin Lymphoma
- CHO-H01
-
The Woodlands, Texas
- +7 more
Jul 10, 2023
NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)
Completed
- Non-Small Cell Lung Cancer
- Brain Neoplasms
- bevacizumab
- +2 more
- (no location specified)
Dec 9, 2022
Flatfoot Trial in Madrid (Bilateral pressure release in Flexor Brevis Digitorum in subjects with latent trigger point, Bilateral
Completed
- Flatfoot
- Bilateral pressure release in Flexor Brevis Digitorum in subjects with latent trigger point
- Bilateral non emission Laser in latent trigger points of the Flexor digitorum Brevis Muscle
-
Madrid, SpainEva María Martínez-Jimenez
May 31, 2023
Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto
Not yet recruiting
- Multiple Sclerosis
- +2 more
- KYV-101 anti-CD19 CAR-T cell therapy
- Standard lymphodepletion regimen
-
Palo Alto, CaliforniaStanford Multiple Sclerosis Center
Nov 13, 2023
Healthy Trial in Edegem (BI 765845, Placebo)
Completed
- Healthy
- BI 765845
- Placebo
-
Edegem, BelgiumSGS Life Science Services - Clinical Research
Nov 27, 2023
Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )
Active, not recruiting
- Non Small Cell Lung Cancer
- CS1001 monoclonal antibody
- CS1001 placebo
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Nov 8, 2022
NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)
Not yet recruiting
- NonHodgkin's Lymphoma Refractory
- N803
- +4 more
-
El Segundo, CaliforniaCSSIFM
Nov 9, 2022
Non-valvular Atrial Fibrillation Trial in Hangzhou (Dual antiplatelet, Novel oral anticoagulant)
Recruiting
- Non-valvular Atrial Fibrillation
- Dual antiplatelet
- Novel oral anticoagulant
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Feb 27, 2023
Elder Trial in Jinan (SIM0417/Ritonavir)
Recruiting
- Elder
-
Jinan, Shandong, ChinaShandong First Medical University
Apr 20, 2023
NSCLC Trial in Guangzhou (SKB264, Pembrolizumab, Carboplatin)
Not yet recruiting
- Non-small Cell Lung Cancer
- SKB264
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University, Cancer Center
Apr 14, 2023